Prognostic Factors Identified Via a Cox Proportional Hazard Cure Model Explain Survival Differences After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Chronic Myeloid Leukemia (CML) Between Two Consecutive Patient Cohorts

Authors
Publication date
1 January 2012
Publisher
'American Society of Hematology'
Doi

    Abstract

    Abstract is not available.

      Similar works

      Full text

      thumbnail-image

      Available Versions

      Kölner UniversitätsPublikationsServer

      redirect
      oaioai:USBKOELN.ub.uni-koeln.de:4...
      Last time updated on 16/05/2021